As we all know, serum AFP and AFP-L3 have been widely used in clinical practice for screening and auxiliary diagnosing of HCC over the past few decades (Gao and Song, 2017; Kim et al., 2018; Yang et al., 2019). Here, AFP is linked to hepatocellular carcinoma.